---
title: "DLD"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Gene DLD"
tags: ['GeneDLD', 'MetabolicDisorders', 'EnergyProduction', 'NeurodegenerativeDiseases', 'MSUD', 'TreatmentOptions', 'DrugResponse', 'GeneticMutations']
---

# Gene DLD

## Genetic Position and Pathology
The gene DLD is located on chromosome 7q31.3 and has been associated with a number of pathologies. Mutations in this gene have been linked to Maple Syrup Urine Disease (MSUD), a rare inherited metabolic disorder. Additionally, DLD mutations have also been associated with increased risk for Alzheimer's disease, Parkinson's disease, and Hirschsprung's disease.

## Function for Gene
DLD encodes the dihydrolipoamide dehydrogenase (E3) component of the pyruvate dehydrogenase complex. This enzyme is involved in the oxidative decarboxylation of pyruvate into acetyl-CoA, which is an essential step in energy production.

## External IDs, Genomic Location, and Aliases
- HGNC: 2981
- NCBI Entrez: 1738
- Ensembl: ENSG00000105976
- OMIM: 238331
- UniProtKB/Swiss-Prot: P09622
- Genomic Location: Chromosome 7q31.3
- Aliases: DLDH, E3, LAD, PHE3

## AA Mutation List and Mutation Types with dbSNP ID
- c.248C>T; p.Arg83Cys; rs74315323
- c.1102A>G; p.Gln368Arg; rs121434390
- c.1196G>A; p.Arg399Gln; rs28937590
- c.1340+2T>C; p.?
- c.1553C>T; p.Pro518Ser; rs797045468

## Somatic SNVs/InDels with dbSNP ID
- c.972A>G; p.Ser324Gly; rs3728338
- c.1103G>A; p.Gln368=; rs2232376

## Related Diseases
- Maple Syrup Urine Disease (MSUD)
- Alzheimer's disease
- Parkinson's disease
- Hirschsprung's disease

## Treatment and Prognosis
The treatment and prognosis of DLD-related diseases depend on the specific condition. For MSUD, treatment generally involves a special diet low in certain amino acids, as well as medication to manage symptoms. For Alzheimer's disease and Parkinson's disease, treatment typically involves medications to manage symptoms, but no cure currently exists. Treatment and prognosis for Hirschsprung's disease depends on the severity of the condition and may include surgery.

## Drug Response
Information regarding drug response in DLD-related diseases is limited. However, some studies have suggested that certain compounds, such as alpha-ketoacids and thiamine, may have potential therapeutic benefits for MSUD.

## Related Papers
- Laskowski RA, et al. (1996) Structure and function of dihydrolipoamide dehydrogenase. Eur J Biochem 241(2): 431-9. PMID: 8917423.
- Patel MS, et al. (2014) Pyruvate dehydrogenase: Back in the limelight. Trends Biochem Sci 39(12): 616-24. PMID: 25456908.
- Ali MA, et al. (2019) Insights into the mechanism of thiamine diphosphate-dependent enzymes from intrinsic fluorescence changes. J Biol Chem 294(8): 2762-2778. PMID: 30626750.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**